Dr. Greg Gerdeman, Ph.D., is a pioneer in researching the endocannabinoid system's physiology. In this episode, he walks us through the complex topic of cannabis and cancer, current dosing, and new research that may better inform patients and the medical community.
Greg researched the ECS for over 20 years and talks about our biological co-evolution with plants and how we can learn to change our health's narrative with this knowledge. He clears up over-simplifications of the ECS, which he sees as a conductor of a 'symphony of biological interaction.' Common misinformation is spread unwittingly through popular demand for sound-byte explanations.
As a Ph.D. student, he discovered that endocannabinoids act as "retrograde messengers" to regulate synaptic plasticity in the brain. These findings have become foundational to a modern understanding of the ECS and the neuroprotective actions of cannabinoids. He later co-directed research on exercise-mediated endocannabinoid signaling, revealing new insights into the "runner's high" and its evolutionary roles in exercise's neurological benefits.
As a college professor, his lab focused on the ancient evolutionary origins of cannabinoid receptors. Upon co-founding a medical cannabis company in Florida, he directed scientific activities at every level of the supply chain, ranging from integrative pest management to product development to physician education. He is a Voluntary Assistant Professor at the USF College of Pharmacy. In addition, "Dr. G "is Chief Scientist of TN Farmaceuticals and is co-founder of Weir Wellness, a newly licensed medical cannabis dispensary in Weirton, West Virginia.
"The endocannabinoid system has liberated cannabis from the drug abuse paradigm into the wellness paradigm. "
Disclaimer: The information presented in this podcast is for educational purposes only, and is not intended to replace professional medical advice. Please consult your doctor if you are in need of medical care, and before making any changes to your health routine.